| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b74695f4c6259a8598b722c1ef6eefa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5c8e8c3e8261efe7e698c7198681b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_565d95a96844cbd80be8be8ef20b4d0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_580bfca3d69f244fae376e625f20144f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2013-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77b41b1d6c5139c2f3a9a7022e4718fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb67b6b31d524786216a9da3f162188c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8365d28e934f5d4e0f7cf20d0c087c3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db727f43f47b9b7fb92097b60399513d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69ca5b7265a2344d611836e6e365ef0b |
| publicationDate |
2015-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2526979-A1 |
| titleOfInvention |
Use of 3- (2-isothiocyanatoethyl) -5-methoxy-1H-indole for the treatment of neurodegenerative diseases |
| abstract |
Use of 3- (2-isothiocyanatoethyl) -5-methoxy-1H-indole for the treatment of neurodegenerative diseases. # The present invention relates to the use of 3- (2-isothiocyanatoethyl) -5-methoxy-1H-indole or a composition comprising 3- (2-isothiocyanatoethyl) -5-methoxy-1H-indole for the treatment of diseases that have a decline in cognitive or motor capacity secondary to neuronal degeneration. The present invention also relates to the use of 3- (2-isothiocyanatoethyl) -5-methoxy-1H-indole for the treatment of other neurodegenerative diseases that occur with high levels of oxidative stress and / or neuroinflammation and / or autoimmune. Preferably, the present invention relates to the use of 3- (2-isothiocyanatoethyl) -5-methoxy-1H-indole for the treatment of Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis, cerebral stroke or Amyotrophic Lateral Sclerosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020012052-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2737709-A1 |
| priorityDate |
2013-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |